The data presented here support the suggestion that the nonspecific genotoxicity driven by the aniline 4′-NO2 group can be functionally uncoupled from its protonophoric activity responsible for the targeted inhibition of p53-deficient cancer cells. This evidence concerns the gene TP53 and cancer.